104 related articles for article (PubMed ID: 2423396)
1. Characterization of Multiplication-Stimulating Activity (MSA) carrier protein.
Lyons RM; Smith GL
Mol Cell Endocrinol; 1986 May; 45(2-3):263-70. PubMed ID: 2423396
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of multiplication-stimulating activity (MSA) carrier protein.
Knauer DJ; Wagner FW; Smith GL
J Supramol Struct Cell Biochem; 1981; 15(2):177-91. PubMed ID: 6086006
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned medium.
Moses AC; Nissley SP; Short PA; Rechler MM; Podskalny JM
Eur J Biochem; 1980 Jan; 103(2):387-400. PubMed ID: 6153979
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells.
Romanus JA; Terrell JE; Yang YW; Nissley SP; Rechler MM
Endocrinology; 1986 May; 118(5):1743-58. PubMed ID: 2422012
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.
Moses AC; Nissley SP; Short PA; Rechler MM; White RM; Knight AB; Higa OZ
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3649-53. PubMed ID: 6932040
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture.
Moses AC; Nissley SP; Passamani J; White RM
Endocrinology; 1979 Feb; 104(2):536-46. PubMed ID: 446374
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.
Knauer DJ; Smith GL
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7252-6. PubMed ID: 7012835
[TBL] [Abstract][Full Text] [Related]
8. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin.
Rechler MM; Nissley SP; King GL; Moses AC; Van Obberghen-Schilling EE; Romanus JA; Knight AB; Short PA; White RM
J Supramol Struct Cell Biochem; 1981; 15(3):253-86. PubMed ID: 6267316
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures.
Rechler MM; Eisen HJ; Higa OZ; Nissley P; Moses AC; Schilling EE; Fennoy I; Bruni CB; Phillips LS; Baird KL
J Biol Chem; 1979 Aug; 254(16):7942-50. PubMed ID: 468799
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of the low molecular weight carrier protein for insulin-like growth factors in rat liver and fibroblasts.
Romanus JA; Yang YW; Nissley SP; Rechler MM
Endocrinology; 1987 Sep; 121(3):1041-50. PubMed ID: 2441976
[TBL] [Abstract][Full Text] [Related]
11. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
[TBL] [Abstract][Full Text] [Related]
12. Immunological cross-reactivity of multiplication-stimulating activity polypeptides.
Moses AC; Nissley SP; Short PA; Rechler MM
Eur J Biochem; 1980 Jan; 103(2):401-8. PubMed ID: 6153980
[TBL] [Abstract][Full Text] [Related]
13. Multiplication-stimulating activity (MSA): a somatomedin-like polypeptide from cultured rat liver cells.
Nissley SP; Rechler MM
Natl Cancer Inst Monogr; 1978 May; (48):167-77. PubMed ID: 748750
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
Hey AW; Browne CA; Thorburn GD
Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
[TBL] [Abstract][Full Text] [Related]
16. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of multiplication-stimulating activity (rat insulin-like growth factor II) by rat embryo fibroblasts.
Adams SO; Nissley SP; Greenstein LA; Yang YW; Rechler MM
Endocrinology; 1983 Mar; 112(3):979-87. PubMed ID: 6681602
[TBL] [Abstract][Full Text] [Related]
18. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
[TBL] [Abstract][Full Text] [Related]
19. The E-domain peptide of rat pro-insulin-like growth factor II (proIGF-II): properties of the peptide in serum and production by rat cell lines.
Hylka VW; Straus DS
Biochim Biophys Acta; 1990 Jan; 1051(1):6-13. PubMed ID: 2297541
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
